Cutler Group LP Veru Inc. Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	SELL	$0.98 - $1.49 $392 - $596	-400 Reduced 50.0%	400 $0
Q1 2023 May 01, 2023	SELL	$1.16 - $6.41 $5,568 - $30,768	-4,800 Reduced 85.71%	800 $0
Q4 2022 Feb 07, 2023	SELL	$4.78 - $15.01 $168,734 - $529,853	-35,300 Reduced 86.31%	5,600 $0
Q3 2022 Oct 25, 2022	SELL	$10.22 - $23.7 $782,852 - $1.82 Million	-76,600 Reduced 65.19%	40,900 $39,000
Q2 2022 Aug 04, 2022	BUY	$4.35 - $15.85 $336,690 - $1.23 Million	77,400 Added 193.02%	117,500 $162,000
Q1 2022 Apr 14, 2022	SELL	$4.55 - $6.41 $10,010 - $14,102	-2,200 Reduced 5.2%	40,100 $4,000
Q4 2021 Jan 18, 2022	SELL	$5.89 - $9.73 $4,123 - $6,811	-700 Reduced 1.63%	42,300 $4,000
Q3 2021 Oct 26, 2021	BUY	$6.78 - $9.89 $229,842 - $335,271	33,900 Added 372.53%	43,000 $13,000
Q2 2021 Jul 19, 2021	BUY	$7.24 - $11.2 $7,964 - $12,320	1,100 Added 13.75%	9,100 $0
Q1 2021 Apr 26, 2021	BUY	$8.05 - $20.78 $63,595 - $164,162	7,900 Added 7900.0%	8,000 $1,000
Q4 2020 Jan 21, 2021	BUY	$2.36 - $9.99 $236 - $999	100 New	100 $0

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.